Table 3 |
|||||
|
Drug use at baseline: Comparison of means between treatment and control groups. |
|||||
| Control Group N = 523 |
Drug Ed Group N = 435 |
Significance Level |
|||
|
|
|||||
| Drug Use Variable |
Mean |
Mean |
t |
df |
p valuea |
|
|
|||||
| B1 Cigarettes (frequency) |
1.38 |
1.45 |
-0.962 |
850 |
0.336 |
| B2 Smokeless tobacco |
1.38 |
1.34 |
0.634 |
951 |
0.526 |
| B3 Cigarettes (amt. smoked) |
1.51 |
1.62 |
-1.047 |
956 |
0.295 |
| B4 Alcohol |
1.64 |
1.51 |
1.611 |
955 |
0.107 |
| B5 Being drunk |
1.28 |
1.31 |
-0.408 |
866 |
0.684 |
| B6 Marijuana |
1.24 |
1.22 |
0.326 |
944 |
0.744 |
| B7 Marijuana (amt. smoked) |
1.19 |
1.21 |
-0.332 |
894 |
0.740 |
| B8 Sniffed glue |
1.11 |
1.11 |
0.132 |
876 |
0.895 |
| B9 LSD |
1.03 |
1.05 |
-0.672 |
802 |
0.502 |
| B10 Amphetamines |
1.07 |
1.13 |
-1.404 |
731 |
0.161 |
| B11 Crack |
1.05 |
1.07 |
-0.836 |
804 |
0.403 |
| B12 Cocaine |
1.06 |
1.07 |
-0.247 |
922 |
0.805 |
| B13 Tranquiller |
1.08 |
1.10 |
-0.513 |
790 |
0.608 |
| B14 Barbiturates |
1.08 |
1.10 |
-0.699 |
732 |
0.485 |
| B15 Crystal Meth |
1.04 |
1.07 |
-0.829 |
769 |
0.407 |
| B16 Amphetamine w/o Rx |
1.09 |
1.08 |
0.022 |
907 |
0.982 |
| B17 Heroin |
1.02 |
1.05 |
-1.078 |
654 |
0.281 |
| B18 Other Narcotics |
1.07 |
1.08 |
-0.257 |
866 |
0.798 |
| B19 Ecstasy |
1.07 |
1.06 |
0.463 |
904 |
0.644 |
| B20 Roofies |
1.02 |
1.06 |
-1.087 |
588 |
0.277 |
| B21 GHB |
1.02 |
1.04 |
-1.126 |
532 |
0.261 |
| B22 Super K |
1.02 |
1.05 |
-1.013 |
626 |
0.311 |
|
|
|||||
|
a Controlling for baseline differences by using an analysis of covariance with a Type III sums of squares, The t-test df is corrected for unequal variances. |
|||||
|
Lennox and Cecchini Substance Abuse Treatment, Prevention, and Policy 2008 3:8 doi:10.1186/1747-597X-3-8 |
|||||